Abstract: Discharge for detecting the position coordinates of an electronic pen is caused stably, and the position coordinates are detected accurately. For this purpose, in a driving method of an image display device, an image display subfield group constituted of image display subfields, a timing detection subfield, a y-coordinate detection subfield, and an x-coordinate detection subfield are set in one field. In the timing detection subfield, a plurality of timing detection pulses for causing timing detection discharge in discharge cells is applied to scan electrodes and sustain electrodes alternately.

Abstract: Discharge for detecting the position coordinates of an electronic pen is caused stably, and the position coordinates are detected accurately. For this purpose, in a driving method of an image display device, an image display subfield, a y-coordinate detection subfield, and an x-coordinate detection subfield are included in one field. In the x-coordinate detection subfield, an x-coordinate detection waiting period is set in which a voltage higher than an x-coordinate detection voltage is applied to the scan electrodes and a voltage lower than the voltage of x-coordinate detection pulses is applied to the data electrodes. After the x-coordinate detection waiting period, the x-coordinate detection voltage is applied to the scan electrodes, and the x-coordinate detection pulses are sequentially applied to the data electrodes.

Abstract: Discharge for detecting the position coordinates of an electronic pen is caused stably, and the position coordinates are detected accurately. For this purpose, in a driving method of an image display device, an image display subfield group constituted of image display subfields, a y-coordinate detection subfield, and an x-coordinate detection subfield are set in one field. An initializing period, in which an up-ramp voltage and a down-ramp voltage are applied to the scan electrodes, is set in the x-coordinate detection subfield, and the x-coordinate detection subfield is disposed immediately after the y-coordinate detection subfield.

Abstract: Discharge for detecting the position coordinates of an electronic pen is caused stably, and the position coordinates are detected accurately. For this purpose, in a driving method of an image display device, an image display subfield, a y-coordinate detection subfield, and an x-coordinate detection subfield are included in one field. In an initializing period of the x-coordinate detection subfield, a first voltage is applied to data electrodes and a first down-ramp voltage is applied to scan electrodes. In the initializing period of the image display subfield, a second voltage is applied to the data electrodes and a second down-ramp voltage is applied to the scan electrodes. The voltage derived by subtracting an arrival voltage of the first down-ramp voltage from the first voltage is set higher than the voltage derived by subtracting an arrival voltage of the second down-ramp voltage from the second voltage.

Abstract: A subfield (SF) coding circuit including an SF coding cache memory, a look-up table (LUT) memory, and an SF coding control unit. The coding control unit reads setting gradation values and SF coding data from the coding cache memory for writing to the LUT memory SF by SF. The control unit accesses the LUT memory by using the gradation value of an image signal from a frame memory control unit as an address, and outputs the SF coding data corresponding to the gradation value of the image signal input to the LUT memory to a serial-to-parallel conversion unit.

Abstract: This invention relates to piperazine derivatives of the formula: wherein each symbol is as defined in the description, and its pharmaceutically acceptable salt, to processes for preparation thereof, to pharmaceutical composition comprising the same, and to a use of the same for treating or preventing Tachykinin-mediated diseases in human being or animals.

Abstract: It is to form a memory access circuit comprising a memory, a clock generator for generating a reference clock signal, and a clock delay adjusting circuit for delaying the reference clock signal to create a delay clock signal. The clock delay adjusting circuit is a circuit for generating a plurality of delay clock signals of various delay value. The memory access circuit further comprises a test data generator for generating test data and a memory access test controller for supplying a memory writing test start signal in reply to the external synchronizing signal.

Abstract: This invention relates to piperazine derivatives of the formula: wherein each symbol is as defined in the description, and its pharmaceutically acceptable salt, to processes for preparation thereof, to pharmaceutical composition comprising the same, and to a use of the same for treating or preventing Tachykinin-mediated diseases in human being or animals.

Abstract: A memory circuit includes a delay circuit for generating a delay clock signal by delaying a reference clock signal, a temperature detection circuit, and a voltage detection circuit. The temperature detection circuit detects the temperature of part around a memory and the voltage detection circuit detects the power-supply voltage of the memory. The delay circuit determines the delay amount of the delay clock signal according to at least one of temperature data detected by the temperature detection circuit and voltage data detected by the voltage detection circuit, whereby a circuit accessing the memory can supply a clock signal without being affected by the temperature change and/or the power-supply voltage fluctuation.

Abstract: This invention relates to piperazine derivatives of formula (I), wherein Y is bond or lower alkylene, R1 is aryl which may have substituent(s), R2 is aryl or indolyl, each of which may have substituent(s), R3 is hydrogen or lower alkyl, and R4 is as defined in the description, and its pharmaceutically acceptable salt, to processes for preparation thereof, to pharmaceutical composition comprising the same, and to a use of the same for treating or preventing Tachykinin-mediated diseases in human beings or animals.

Abstract: This invention relates to piperazine derivatives of the formula: 1

Abstract: This application is a 371 of PCT/JP96/03641 filed Dec. 12, 1996.

Abstract: This invention relates to piperazine derivatives of the formula: wherein each symbol is as defined in the description, and its pharmaceutically acceptable salt, to processes for preparation thereof, to pharmaceutical composition comprising the same, and to a use of the same for treating or Tachykinin-mediated diseases in human beings or animals.

Abstract: A piperazine compound of the formula: ##STR1## wherein: X is carbonyl or sulfonyl;Y is a direct bond or lower alkylene; andR.sub.1, R.sub.2, R.sub.3, R.sub.4 are as defined herein. The compounds are advantageously used as Tachykinin antagonists in the treatment of respiratory diseases, ophthalmic diseases and inflammatory diseases, for example.

Abstract: A piperazine compound of the formula: ##STR1## wherein: X is carbonyl or sulfonyl;Y is a direct bond or lower alkylene; andR.sub.1, R.sub.2, R.sub.3, R.sub.4 are as defined herein. The compounds are advantageously used as Tachykinin antagonists in the treatment of respiratory diseases, ophthalmic diseases and inflammatory diseases, for example.

Abstract: The invention relates to a compound of the formula: ##STR1## in which R.sup.1 and R.sup.2 are each hydrogen or lower alkyl,R.sup.3 is aryl or unsaturated, 5- or 6-membered heterocyclic group containing a sulfur atom, each of which may be substituted by one or more substituent(s) selected from the group consisting of halogen, hydroxy, lower alkyl, aryloxy, trihalo(lower)alkyl, lower alkoxy and mono- or di(lower)alkylamino,R.sup.4 is hydrogen, halogen or lower alkyl,A is methylene, methine, oxa, thia, sulfinyl or sulfonyl,Y is vinylene or ethylene.Z is a group of the formula: ##STR2## wherein R.sup.5 is carboxy or protected carboxy, andR.sup.6 is hydrogen or hydroxy-protective group, andthe line is of a single or double bond, or a pharmaceutically acceptable salt thereof, useful as a 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor.

Abstract: The invention relates to novel indolylpiperidine compounds useful in the treatment of allergic disease and inflammation.

Abstract: The invention relates to new compounds, of antiallergic activity, of the formula: ##STR1## wherein R.sup.1 is aryl substituted with substituent(s) selected from the group consisting of hydroxy, protected hydroxy, halogen and lower alkoxy, A is lower alkylene, and B is lower alkenylene, or a pharmaceutically acceptable salt thereof.

Abstract: A thiazole compound of the formula: ##STR1## wherein R.sup.1 is amino or acylamino,R.sup.2 is ar(lower)alkoxy, andA is lower alkylene,and a pharmaceutically acceptable salt thereof, processes for the preparation thereof and pharmaceutical composition comprising the same.